Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report

Elisabetta Bussalino, Andrea De Maria, Rodolfo Russo, Ernesto Paoletti

Research output: Contribution to journalArticlepeer-review

Abstract

The role of systemic inflammation is proving crucial in determining unfavorable outcome in SARS-CoV-2–infected patients. Limited data are available regarding immunosuppression management in kidney transplant recipients (KTRs) with SARS-CoV-2 pneumonia. We report a case of a 32-year-old KTR who developed SARS-CoV-2 infection and fully recovered in 15 days while maintaining standard immunosuppressive therapy.

Original languageEnglish
Pages (from-to)1922-1924
Number of pages3
JournalAmerican Journal of Transplantation
Volume20
Issue number7
DOIs
Publication statusPublished - Jul 1 2020

Keywords

  • clinical research/practice
  • immunosuppressive regimens
  • infection and infectious agents—viral
  • kidney transplantation/nephrology

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report'. Together they form a unique fingerprint.

Cite this